Press Release

India In-vitro Diagnostic Reagents Market to Grow with a CAGR of 6.55% through 2030

The integration of advanced technologies and increasing incidence of chronic diseases are expected to drive the India In-vitro Diagnostic Reagents Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “India In-vitro Diagnostic Reagents Market – By Region, Competition, Forecast and Opportunities, 2030F”, the India In-vitro Diagnostic Reagents Market stood at USD 1.68 billion in 2024 and is anticipated to grow with a CAGR of 6.55% in the forecast period through 2030.

Integration of cutting-edge technologies such as molecular diagnostics, next-generation sequencing, and advanced immunoassays has significantly improved the accuracy, speed, and reliability of diagnostic tests, making them attractive for investment and expanding market opportunities. Automation and digitalization in laboratory systems have streamlined workflows, reduced errors, and increased diagnostic capacity, meeting the rising demand for precise diagnostics in India.

Demographic shifts, including an increasing burden of chronic diseases like diabetes, cardiovascular conditions, and cancer, necessitate frequent, reliable diagnostic testing, thereby driving demand for IVD reagents. The aging population, susceptible to chronic and age-related illnesses, requires comprehensive diagnostic solutions for timely medical interventions. Expansion of healthcare infrastructure through investments in hospitals, diagnostic centers, and laboratories enhances diagnostic service accessibility across urban and rural areas. Government initiatives such as Ayushman Bharat are expanding healthcare coverage, making diagnostic tests more accessible and contributing to market growth for IVD reagents. Rising health consciousness prompts proactive health management, increasing demand for regular diagnostic testing and IVD reagents.

Health awareness campaigns by governmental and non-governmental organizations emphasize the importance of regular health screenings, fostering a culture of preventive healthcare and stimulating market expansion. Economic growth in India has boosted disposable incomes, enabling more individuals to afford advanced healthcare services, including diagnostic tests. Increased healthcare spending by public and private sectors supports infrastructure, services, and technology improvements, crucial for sustained growth in the IVD reagents market. Strategic collaborations among diagnostic firms, research institutions, and healthcare providers drive innovation, expand market reach, and enhance the diagnostic ecosystem.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " India In-vitro Diagnostic Reagents Market

 

The India In-vitro Diagnostic Reagents Market is segmented into test type, product, usability, application, end user, regional distribution, and company.

Based on its application, the infectious diseases segment has emerged as the predominant market leader, India faces significant challenges due to endemic infectious diseases like tuberculosis (TB), malaria, dengue, hepatitis, and more recently, COVID-19. These diseases persist and spread in the country's large population density and diverse environmental conditions, underscoring the need for robust diagnostic capabilities. Periodic outbreaks of infectious diseases, such as seasonal flu and viral fevers, necessitate rapid and accurate diagnostic testing to effectively contain their spread. Diagnostic tests that detect specific pathogens during outbreaks play a crucial role in mounting timely public health responses.

The infectious disease segment requires a diverse array of diagnostic tests, including molecular assays, serological tests (ELISA), rapid antigen tests, and nucleic acid amplification tests (NAATs). These tests are essential for detecting viral, bacterial, and parasitic infections, providing clinicians with critical information for patient management. Government initiatives and public health programs often incorporate screening for infectious diseases, particularly among high-risk populations. These programs drive the demand for diagnostic tests capable of early detection, enabling prompt treatment and effective disease control measures.

Technological advancements in diagnostic technologies have revolutionized infectious disease diagnostics, improving sensitivity, specificity, and testing speed. Molecular diagnostic techniques like PCR and next-generation sequencing (NGS) enable rapid and accurate pathogen detection, facilitating timely clinical decision-making. The development of rapid diagnostic tests and point-of-care testing (POCT) devices for infectious diseases has streamlined diagnostic workflows. These tests deliver quick results at or near the patient’s location, enabling immediate medical interventions and reducing the risk of disease transmission.

 

Major companies operating in India In-vitro Diagnostic Reagents Market are:

  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Transasia Bio-Medicals Ltd
  • Thermo Fisher Scientific Inc

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“India In-vitro Diagnostic Reagents market demonstrates robust growth prospects driven by expanding healthcare infrastructure, technological advancements enhancing diagnostic precision, and proactive government initiatives promoting healthcare accessibility. With increasing disease prevalence and a growing emphasis on preventive healthcare, the market is poised for continued expansion, supported by ongoing innovations and strategic investments in diagnostic capabilities across the country”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

India In-vitro Diagnostic Reagents Market, By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other), By Product (Instrument, Reagent, Other), By Usability (Disposable, Reusable), By Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, Other), By End User (Diagnostic Laboratories, Hospitals and Clinics, Other), By Region, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of India In-vitro Diagnostic Reagents Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India In-vitro Diagnostic Reagents Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News